Michael Petruny
Geen lopende functies
Profiel
Michael Petruny worked as a Director-Immunology Sales at Fujisawa Healthcare, Inc., a Regional Manager at Enzon Pharmaceuticals, Inc., and a Vice President-Sales at Cylex, Inc. He received undergraduate and graduate degrees from Louisiana State University.
Eerdere bekende functies van Michael Petruny
| Bedrijven | Functie | Einde |
|---|---|---|
Cylex, Inc.
 Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Verkoop & Marketing | 18-11-2013 |
| ENZON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| Fujisawa Healthcare, Inc. | Verkoop & Marketing | - |
Opleiding van Michael Petruny
| Louisiana State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Cylex, Inc.
Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Health Technology |
| Fujisawa Healthcare, Inc. |
